CD11b (Myeloid Marker), in Visit Clinic

Yes. CD11b (integrin αM, ITGAM) is widely used as a myeloid-lineage marker: it is highly expressed on neutrophils, monocytes, macrophages, many dendritic cell subsets and NK cells, and increases on activated myeloid cells. CD11b forms part of the Mac-1 integrin involved in adhesion, migration and phagocytosis, so its detection helps identify myeloid populations.

Yes. CD15 (Lewis X) is primarily expressed on myeloid cells—especially granulocytes such as neutrophils and eosinophils—and is used as a myeloid/granulocytic differentiation marker in hematology and pathology. However, it is not entirely specific to myeloid lineage: some monocytes, certain lymphoid or epithelial cell subsets, and some tumors can also express CD15, so it’s interpreted with other markers.

CD11b (integrin αM) is a myeloid-lineage marker found on monocytes, macrophages, neutrophils and other myeloid cells. It is not specific to M1 or M2 polarization—both macrophage subsets can express CD11b, with expression levels varying by activation state. Thus CD11b is a general myeloid/macrophage marker, not a definitive M1 versus M2 discriminator.

Yes. CD13 (aminopeptidase N) is commonly used as a myeloid lineage marker because it is expressed on neutrophils, monocytes and early myeloid progenitors. However, it is not entirely specific — CD13 is also present on some non‑myeloid cells (epithelial, endothelial cells, fibroblasts) and certain tumors, so it is interpreted alongside other markers in diagnostic immunophenotyping.

CD11b (integrin αM) is a myeloid cell surface integrin that pairs with CD18 to form complement receptor 3 (CR3). It mediates leukocyte adhesion, migration, phagocytosis and binding of iC3b, playing a central role in innate immunity and inflammation. Clinically and in research, CD11b is used as a marker of myeloid cell presence, activation, and to monitor inflammatory or immune-related conditions.

Myeloid markers are proteins and enzymes expressed on or in myeloid-lineage blood cells (e.g., monocytes, granulocytes, macrophages, dendritic cells). Common markers include CD13, CD14, CD15, CD33, CD11b and myeloperoxidase. They’re detected by flow cytometry or immunohistochemistry to identify cell lineage, maturation stage and diagnose or classify myeloid disorders such as acute myeloid leukemia.